Description
98% Min Medical Grade 20KG/Drum Valsartan Raw Powder CAS 137862-53-4
Description
| Name: | Valsartan | CAS No.: | 137862-53-4 |
|---|---|---|---|
| Molecular Formula: | C24H29N5O3 | Molecular Weight: | 435.52 |
| Melting Point: | 116-117°C | Storage: | −20°C |
| Package: | 1KG/bag, 20KG/drum | Purity: | 98% Min |
| MOQ: | 1KG, 20KG | ||
| High Light: |
98% Min Medical Valsartan Raw Powder, Valsartan CAS 137862-53-4, 20KG/Drum Valsartan Raw Powder |
||
98% min medical grade valsartan raw powder CAS 137862-53-4 20KG/drum
What is valsartan?
Valsartan is an angiotensin II receptor blocker (sometimes called an ARB).
Valsartan is used to treat high blood pressure (hypertension) in adults and children who are at least 1 year old. Lowering blood pressure may lower your risk of a stroke or heart attack.
Valsartan is also used in adults to treat heart failure and lower your risk of needing to be hospitalized, and to lower your risk of death after a heart attack.
Valsartan dosing information
Usual Adult Dose for Congestive Heart Failure:
Initial dose: 40 mg orally twice a day
Maintenance dose: 80 to 160 mg twice a day. The dose should be increased to the highest dose tolerated by the patient.
Usual Adult Dose for Hypertension:
Initial dose: 80 to 160 mg orally once a day.
Maintenance dose: 80 to 320 mg orally once a day
Usual Adult Dose for Myocardial Infarction:
Initial dose: 20 mg orally twice a day
Maintenance dose: The initial dosage may be titrated upward within 7 days to 40 mg twice daily, with subsequent titrations to a target maintenance dose of 160 mg twice a day as tolerated by the patient. If symptomatic hypotension or renal dysfunction occurs, consideration should be given to a dosage reduction.
Comment: Valsartan may be initiated as early as 12 hours after a myocardial infarction, and may be given with other standard postmyocardial infarction treatment, including thrombolytics, aspirin, beta blockers, and statins.
Usual Pediatric Dose for Hypertension:
6 to 16 years:
Initial dose: 1.3 mg/kg once a day (up to 40 mg)
Maintenance dose: up to 2.7 mg/kg (up to 160 mg) once a day titrated according to patient response
Comments:
-If the calculated dosage does not correspond to the available tablet strengths, or if children are unable to swallow tablets, the use of a suspension (which can be prepared from the tablets) is recommended. The valsartan dose may need to be increased if the suspension is replaced by a tablet.
-No data are available in pediatric patients either undergoing dialysis or with a glomerular filtration rate less than 30 mL/min.
Note
Call your doctor for medical advice about any side effects.
